Boehringer Ingelheim convinces NICE that Pradaxa is cost-effective
01 November 2011
Francesca Bruce
Please Login to read the full article.
01 November 2011
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- NICE needs more info on Pradaxa before it can win warfarin replacement race
- Pradaxa finally wins English warfarin replacement race, despite appeal
- Bayer must convince NICE it has not overestimated the effectiveness of Xarelto
- BMS/Pfizer's Eliquis better than Lovenox, but comparison with Pradaxa and Xarelto not clear, says NICE
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
